Proto Other Current Liab vs Non Current Liabilities Total Analysis
PRLB Stock | USD 40.80 0.31 0.75% |
Proto Labs financial indicator trend analysis is much more than just breaking down Proto Labs prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Proto Labs is a good investment. Please check the relationship between Proto Labs Other Current Liab and its Non Current Liabilities Total accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Proto Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Proto Stock refer to our How to Trade Proto Stock guide.
Other Current Liab vs Non Current Liabilities Total
Other Current Liab vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Proto Labs Other Current Liab account and Non Current Liabilities Total. At this time, the significance of the direction appears to have weak relationship.
The correlation between Proto Labs' Other Current Liab and Non Current Liabilities Total is 0.34. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Proto Labs, assuming nothing else is changed. The correlation between historical values of Proto Labs' Other Current Liab and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of Proto Labs are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Other Current Liab i.e., Proto Labs' Other Current Liab and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.34 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Other Current Liab
Non Current Liabilities Total
Most indicators from Proto Labs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Proto Labs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Proto Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Proto Stock refer to our How to Trade Proto Stock guide.At present, Proto Labs' Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 26.98, whereas Selling General Administrative is forecasted to decline to about 38.8 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 222.7M | 215.5M | 222.0M | 168.5M | Total Revenue | 488.1M | 488.4M | 503.9M | 325.0M |
Proto Labs fundamental ratios Correlations
Click cells to compare fundamentals
Proto Labs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Proto Labs fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 27.0M | 26.9M | 27.7M | 27.4M | 26.2M | 26.3M | |
Total Assets | 673.7M | 744.2M | 928.6M | 802.2M | 772.4M | 487.9M | |
Other Current Liab | 27.4M | 24.4M | 21.8M | 16.0M | 30.3M | 17.9M | |
Total Current Liabilities | 47.6M | 50.3M | 54.9M | 71.6M | 49.7M | 35.8M | |
Total Stockholder Equity | 585.8M | 644.4M | 828.5M | 697.6M | 695.3M | 422.6M | |
Property Plant And Equipment Net | 275.1M | 294.9M | 287.8M | 279.2M | 259.2M | 170.1M | |
Net Debt | (113.3M) | (114.3M) | (58.5M) | (35.2M) | (78.3M) | (82.2M) | |
Retained Earnings | 324.7M | 362.9M | 376.7M | 258.2M | 256.4M | 178.4M | |
Accounts Payable | 16.8M | 18.2M | 25.4M | 17.4M | 15.6M | 13.2M | |
Cash | 125.2M | 127.6M | 65.9M | 56.6M | 83.8M | 61.4M | |
Non Current Assets Total | 437.2M | 502.2M | 745.1M | 615.6M | 571.7M | 334.6M | |
Cash And Short Term Investments | 160.7M | 161.7M | 77.5M | 80.1M | 102.8M | 90.4M | |
Net Receivables | 57.5M | 58.4M | 81.4M | 80.3M | 75.1M | 46.2M | |
Short Term Investments | 35.4M | 34.1M | 11.6M | 23.6M | 19.0M | 29.0M | |
Liabilities And Stockholders Equity | 673.7M | 744.2M | 928.6M | 802.2M | 772.4M | 487.9M | |
Non Current Liabilities Total | 40.3M | 49.6M | 45.2M | 32.9M | 27.4M | 29.5M | |
Inventory | 10.1M | 10.9M | 13.2M | 13.6M | 13.7M | 9.1M | |
Other Current Assets | 8.2M | 11.0M | 11.5M | 12.6M | 9.1M | 7.7M | |
Other Stockholder Equity | 268.1M | 284.8M | 468.5M | 473.7M | 466.9M | 241.8M | |
Total Liab | 87.9M | 99.8M | 100.1M | 104.5M | 77.1M | 65.3M | |
Property Plant And Equipment Gross | 275.1M | 294.9M | 280.3M | 279.2M | 489.4M | 513.9M | |
Total Current Assets | 236.4M | 242.0M | 183.5M | 186.6M | 200.7M | 153.4M | |
Accumulated Other Comprehensive Income | (7.0M) | (3.4M) | (16.8M) | (34.4M) | (28.0M) | (26.6M) | |
Other Liab | 31.7M | 40.1M | 41.6M | 30.7M | 35.3M | 37.1M | |
Property Plant Equipment | 263.7M | 282.7M | 287.8M | 257.8M | 296.5M | 169.1M | |
Net Tangible Assets | 585.8M | 515.6M | 389.9M | 392.4M | 451.3M | 401.7M | |
Non Currrent Assets Other | 3.0M | 4.8M | 4.3M | 4.8M | 4.9M | 2.8M | |
Other Assets | 3.0M | 53.9M | 4.3M | 4.8M | 5.5M | 7.4M | |
Retained Earnings Total Equity | 324.7M | 362.9M | 376.7M | 258.2M | 297.0M | 220.6M | |
Capital Surpluse | 268.1M | 284.8M | 468.5M | 473.7M | 544.8M | 299.4M | |
Long Term Investments | 13.0M | 59.4M | 14.3M | 26.4M | 8.0M | 7.6M | |
Non Current Liabilities Other | 5.4M | 1.9M | 5.7M | 4.4M | 5.0M | 4.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Proto Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Proto Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Proto Labs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Proto Labs Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Proto Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Proto Stock refer to our How to Trade Proto Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Proto Labs. If investors know Proto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Proto Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 0.94 | Revenue Per Share 19.816 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0242 |
The market value of Proto Labs is measured differently than its book value, which is the value of Proto that is recorded on the company's balance sheet. Investors also form their own opinion of Proto Labs' value that differs from its market value or its book value, called intrinsic value, which is Proto Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Proto Labs' market value can be influenced by many factors that don't directly affect Proto Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Proto Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Proto Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Proto Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.